Since there is an ongoing obesity epidemic, nuclear InsR, which appears to play a differential role in overweight or obese compared to normal-weight patients, warrants further investigation in an independent study, preferably in randomized clinical trials of IGF-targeting treatments. Here, INSR is linked to obesity due to melanocortin 4 receptor deficiency.